Event Brief
Oct 22, 2026 at 8:00 PM ET
L'Oréal CEO says GLP-1 use is affecting sales
By The BriefBrief
L'Oréal's CEO said the use of GLP-1 drugs, including weight-loss medications, is affecting the company's beauty and skin-care sales, calling their use “a very important phenomenon” for the business. Separately, EY-Parthenon research found weight loss had become the most popular use of the drugs, which were once dedicated to diabetes patients.
WHO: L'Oréal's CEO
WHAT: L'Oréal's CEO said GLP-1 drug use is affecting the company's beauty and skin-care sales.
WHEN: Reported Oct 22, 2026 at 6:27 PM ET
WHERE: France
WHY: GLP-1 drug use is affecting beauty and skin-care sales; the CEO did not give a further reason for the impact.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
UN chief says Sudan hospital attacks may be war crimes
Volker Türk
Oct 22, 2026 at 7:35 PM ET
Mother sues Hillsborough County school board
School Board
Oct 22, 2026 at 7:20 PM ET
Duffy visits Largo radar plant tied to air traffic overhaul
Sean Duffy
Oct 22, 2026 at 7:20 PM ET
Trump invokes defense law to support oil activities
Donald Trump
Oct 22, 2026 at 7:12 PM ET
